IBDEI2RA ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43957,0)
 ;;=G30.1^^164^2169^3
 ;;^UTILITY(U,$J,358.3,43957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43957,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,43957,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,43957,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,43958,0)
 ;;=B20.^^164^2169^21
 ;;^UTILITY(U,$J,358.3,43958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43958,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,43958,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,43958,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,43959,0)
 ;;=G10.^^164^2169^22
 ;;^UTILITY(U,$J,358.3,43959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43959,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,43959,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,43959,2)
 ;;=^5003751
 ;;^UTILITY(U,$J,358.3,43960,0)
 ;;=G30.8^^164^2169^1
 ;;^UTILITY(U,$J,358.3,43960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43960,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,43960,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,43960,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,43961,0)
 ;;=A81.89^^164^2169^5
 ;;^UTILITY(U,$J,358.3,43961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43961,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,43961,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,43961,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,43962,0)
 ;;=G20.^^164^2169^26
 ;;^UTILITY(U,$J,358.3,43962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43962,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,43962,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,43962,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,43963,0)
 ;;=G23.1^^164^2169^30
 ;;^UTILITY(U,$J,358.3,43963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43963,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,43963,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,43963,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,43964,0)
 ;;=F03.91^^164^2169^16
 ;;^UTILITY(U,$J,358.3,43964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43964,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,43964,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,43964,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,43965,0)
 ;;=F03.90^^164^2169^18
 ;;^UTILITY(U,$J,358.3,43965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43965,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,43965,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,43965,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,43966,0)
 ;;=G31.84^^164^2169^23
 ;;^UTILITY(U,$J,358.3,43966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43966,1,3,0)
 ;;=3^Mild Cognitive Impairment,So Stated
 ;;^UTILITY(U,$J,358.3,43966,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,43966,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,43967,0)
 ;;=F02.81^^164^2169^14
 ;;^UTILITY(U,$J,358.3,43967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43967,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/ Behav Dist
 ;;^UTILITY(U,$J,358.3,43967,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,43967,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,43968,0)
 ;;=F02.80^^164^2169^15
 ;;^UTILITY(U,$J,358.3,43968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43968,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/o Behav Dist
 ;;^UTILITY(U,$J,358.3,43968,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,43968,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,43969,0)
 ;;=A81.01^^164^2169^9
